2.13. Anti-IL17A Treatments Halts Capillary Degeneration and the Early Onset of Diabetic Retinopathy in Leprdb Type II Diabetic Mice 6 Months Post-Diabetes. This evidence concerns the gene IL17A and diabetic retinopathy.